NMIBC Risk Calculator (EORTC-style)
Use this calculator to estimate recurrence and progression risk for non-muscle invasive bladder cancer (NMIBC) based on common clinicopathologic factors.
Educational tool only. This NMIBC recurrence calculator does not replace physician judgment, guideline-based care, pathology review, or shared decision-making.
What is an NMIBC calculator?
An NMIBC calculator estimates the chance of disease recurrence and progression in patients with non-muscle invasive bladder cancer. These tools combine key pathology and clinical variables to support risk stratification after transurethral resection and during follow-up planning.
In clinical practice, risk estimation helps answer practical questions such as:
- How intensive should cystoscopy surveillance be?
- What is the likely benefit of intravesical therapy (for example, BCG)?
- How urgently should high-risk features be addressed with specialist input?
How this calculator works
This page uses a simplified EORTC-style point system based on six standard factors:
- Number of tumors
- Tumor size
- Prior recurrence rate
- T category (Ta vs T1)
- Concomitant CIS
- Grade (WHO 1973)
Two separate scores are generated:
- Recurrence score (risk of tumor coming back)
- Progression score (risk of progression to more aggressive disease)
Interpreting your NMIBC recurrence and progression result
1) Recurrence estimate
The recurrence estimate provides approximate 1-year and 5-year probabilities. A higher score means a higher chance of tumor recurrence and usually supports closer monitoring and proactive adjuvant treatment discussions.
2) Progression estimate
The progression estimate is often the most clinically impactful part of risk calculation. Even if recurrence risk is moderate, progression risk can alter the intensity of management and referral pathways.
3) Why both scores matter
Some patients recur frequently but rarely progress; others have less frequent recurrence yet meaningful progression risk. Looking at both dimensions gives a clearer and safer picture than using one score alone.
Practical use in clinic workflow
A risk tool is most useful when paired with pathology quality, complete tumor resection, and guideline-aligned follow-up. Typical workflow includes:
- Confirm pathology (stage, grade, CIS status)
- Apply risk calculator
- Assign provisional risk group (low/intermediate/high/very high concern)
- Align treatment and surveillance strategy with local and international guidelines
- Reassess after each follow-up cystoscopy and pathology update
Important limitations
No NMIBC risk calculator can capture every individual variable. Results are population-based estimates and should be interpreted in context. Real-world outcomes can be influenced by:
- Restaging quality and completeness of TURBT
- Use, timing, and maintenance of intravesical therapy
- Pathology variation between institutions
- Patient age, comorbidities, and treatment tolerance
- Guideline updates and evolving evidence
Frequently asked questions
Is this a medical diagnosis tool?
No. It is a decision-support calculator for education and structured discussion. A urologist or uro-oncology team should interpret results.
Can this replace cystoscopy follow-up?
No. Surveillance remains essential in NMIBC, even in lower-risk patterns.
Why are percentages approximate?
They are derived from risk groups and historical cohorts. Individual outcomes may differ based on modern treatment protocols and patient-specific factors.
Bottom line
This NMIBC calculator is designed to make bladder cancer risk discussion clearer and more consistent. Use it to organize information, not to make isolated decisions. The best care comes from combining risk scores, pathology review, patient goals, and expert clinical judgment.